August 19, 2025
Editorial commentary: Understanding the cardiovascular benefits of glucagon-like peptide-1 (GLP-1) receptor agonists. Trends in Cardiovascular Medicine. 2024.
Over the last two decades the therapeutic options for management of type 2 diabetes and obesity have dramatically expanded. The mandated cardiovascular safety trials have uncovered further therapeutic benefits of glucagon-like peptide-1 receptor agonist. ...
